SciELO - Scientific Electronic Library Online

 
vol.14 número2Prophylactic use of palivizumab in the prevention of respiratory syncytial virus infection in high-risk childrenLow molecular weight heparins for prophylaxis and treatment of deep venous thrombosis in pregnancy índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

BIS. Boletim do Instituto de Saúde (Impresso)

versión impresa ISSN 1518-1812

Resumen

BERSUSA, Ana Aparecida Sanches; LOUVISON, Marilia Cristina Prado  y  BONFIM, José Ruben de Alcântara. Treatment of adults with chronic hepatitis C virus genotype 1 with protease inhibitors (boceprevir and telaprevir or). BIS, Bol. Inst. Saúde (Impr.) [online]. 2013, vol.14, n.2, pp. 221-228. ISSN 1518-1812.

It presents systematic reviews and meta-analyzes, and coverage policies on the use of protease inhibitors (boceprevir and telaprevir) to treat adult patients infected with hepatitis C genotype 1, comparing the treatment of peginterferon alfa and ribavirin with peginterferon alfa ribavirin and protease inhibitor. It was shown that the addition of protease inhibitor has significant impact on the sustained virologic outcome.

Palabras llave : Hepatitis C; Protease Inhibitors; Interferons.

        · resumen en Portugués     · texto en Portugués     · pdf en Portugués